Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Allanore · SciRah

Researcher profile · Semantic Scholar

Y. Allanore

Share profile

Y. Allanore — researcher profile on SciRah

h-index: 96
Works: 731
Citations: 39K

Most-cited papers

Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment
C. Bruni, M. Buch, A. Djokovic, G. de Luca +31 more
2023Journal of Scleroderma and Related Disorders51 citations Open access
Semantic Scholar
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
E. Zanatta, Elisabetta Cocconcelli, G. Castelli, C. Giraudo +20 more
2023RMD Open40 citations Open access
Semantic Scholar
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON
Y. Allanore, M. Vonk, O. Distler, Azuma Arata +7 more
2022Annals of the Rheumatic Diseases40 citations Open access
Semantic Scholar
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort
S. Kuster, S. Jordan, M. Elhai, U. Held +35 more
2022RMD Open34 citations Open access
Semantic Scholar
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
A. Lescoat, Suiyuan Huang, P. Carreira, E. Siegert +14 more
2023JAMA dermatology33 citations Open access
Semantic Scholar
Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital.
S. Hecquet, A. Combier, A. Steelandt, M. Pons +5 more
2023Rheumatology30 citations
Semantic Scholar
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis
S. Guler, Adela-Cristina Sarbu, O. Stalder, Y. Allanore +16 more
2023Thorax30 citations Open access
Semantic Scholar
Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis
J. Avouac, A. Cauvet, C. Orvain, M. Boulch +7 more
2023Arthritis & Rheumatology30 citations Open access
Semantic Scholar
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
D. Khanna, Toby M. Maher, E. Volkmann, Y. Allanore +9 more
2023RMD Open26 citations Open access
Semantic Scholar
Driving Role of Interleukin‐2–Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis
C. Frantz, A. Cauvet, A. Durand, V. Gonzalez +13 more
2022Arthritis & Rheumatology24 citations
Semantic Scholar
Dyspnoea and cough in patients with systemic sclerosis–associated interstitial lung disease in the SENSCIS trial
E. Volkmann, M. Kreuter, A. Hoffmann-Vold, M. Wijsenbeek +8 more
2022Rheumatology23 citations Open access
Semantic Scholar
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: an EUSTAR database analysis.
C. Campochiaro, A. Hoffmann-Vold, J. Avouac, J. Henes +13 more
2022Rheumatology22 citations Open access
Semantic Scholar
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine.
A. Lescoat, S. Bellando-Randone, C. Campochiaro, F. del Galdo +8 more
2023The Lancet Rheumatology21 citations Open access
Semantic Scholar
Effect of Nintedanib on Progression of Systemic Sclerosis‐Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
S. Assassi, O. Distler, Y. Allanore, T. Ogura +7 more
2022ACR Open Rheumatology21 citations Open access
Semantic Scholar
Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis from EUSTAR.
A. Hoffmann-Vold, C. Brunborg, P. Airó, L. Ananyeva +11 more
2022Chest21 citations Open access
Semantic Scholar
Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials.
A. Hoffmann-Vold, E. Volkmann, Y. Allanore, S. Assassi +6 more
2022The Lancet Rheumatology21 citations Open access
Semantic Scholar
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models
C. Orvain, A. Cauvet, A. Prudent, C. Guignabert +11 more
2022Arthritis Research & Therapy20 citations Open access
Semantic Scholar
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region.
A. Lescoat, D. Huscher, N. Schoof, P. Airó +13 more
2022Rheumatology20 citations Open access
Semantic Scholar
Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review
E. Matteson, M. Matucci-Cerinic, M. Kreuter, G. Burmester +5 more
2023RMD Open18 citations Open access
Semantic Scholar
Systemic Sclerosis Associated Interstitial Lung Disease: A Conceptual Framework for Subclinical, Clinical, and Progressive Disease.
D. Roofeh, K. Brown, E. Kazerooni, D. Tashkin +49 more
2022Rheumatology18 citations Open access
Semantic Scholar
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.
A. Garaiman, K. Steigmiller, Cathérine Gebhard, C. Mihai +18 more
2022Rheumatology18 citations Open access
Semantic Scholar
OP0234 2023 UPDATE OF EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS
F. del Galdo, A. Lescoat, P. Conaghan, L. Ananyeva +23 more
2023Annals of the Rheumatic Diseases17 citations Open access
Semantic Scholar
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort.
E. Zanatta, D. Huscher, A. Ortolan, J. Avouac +16 more
2022Rheumatology15 citations Open access
Semantic Scholar
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review
L. Ross, N. Maltez, M. Hughes, J. Schoones +17 more
2023Rheumatology14 citations Open access
Semantic Scholar
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment
C. Bruni, S. Heidenreich, A. Duenas, A. Hoffmann-Vold +14 more
2022Rheumatology14 citations Open access
Semantic Scholar
Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts.
S. Liem, M. Boonstra, S. le Cessie, A. Riccardi +10 more
2022The Lancet Rheumatology14 citations Open access
Semantic Scholar
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
M. Kerick, M. Acosta-Herrera, C. Simeón-Aznar, J. Callejas +141 more
2022npj Genomic Medicine13 citations Open access
Semantic Scholar
The phenotype of mixed connective tissue disease patients having associated interstitial lung disease.
G. Boleto, S. Reiseter, A. Hoffmann-Vold, A. Mirouse +16 more
2023Seminars in Arthritis & Rheumatism12 citations Open access
Semantic Scholar
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial.
O. Distler, Y. Allanore, C. Denton, M. Kuwana +23 more
2023The Lancet Rheumatology12 citations Open access
Semantic Scholar
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database
G. Lepri, C. Bruni, Lorenzo Tofani, A. Moggi-Pignone +22 more
2024Diagnostics11 citations Open access
Semantic Scholar
Evaluation of Patients With Rheumatoid Arthritis in Teleconsultation During the First Wave of the COVID-19 Pandemic
J. Avouac, A. Moltó, C. Frantz, S. Wanono +6 more
2022Journal of Rheumatology11 citations Open access
Semantic Scholar
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
Y. Allanore, D. Khanna, V. Smith, M. Aringer +6 more
2023Rheumatology10 citations Open access
Semantic Scholar
The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution.
G. Lepri, M. Hughes, Y. Allanore, C. Denton +7 more
2023The Lancet Rheumatology10 citations Open access
Semantic Scholar
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease
M. Hughes, Y. Allanore, M. Baron, F. del Galdo +12 more
2022The Lancet Rheumatology10 citations Open access
Semantic Scholar
Surgical management of digital ulcers in systemic sclerosis: A systematic literature review.
Y. Suliman, C. Campochiaro, Michael Hughes, J. Schoones +17 more
2023Seminars in Arthritis & Rheumatism9 citations Open access
Semantic Scholar
Progressive interstitial lung disease is frequent also in late disease stages in systemic sclerosis patients from EUSTAR
A. Hoffmann-Vold, C. Brunborg, P. Airó, L. Ananyeva +11 more
202212.02 - ILD/DPLD of known origin9 citations
Semantic Scholar
Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis?
C. Campochiaro, Y. Allanore, Y. Braun-Moscovici, M. Cerinic +1 more
2023Autoimmunity Reviews8 citations Open access
Semantic Scholar
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review.
C. Campochiaro, Y. Suliman, Michael Hughes, J. Schoones +17 more
2023Seminars in Arthritis & Rheumatism8 citations Open access
Semantic Scholar
Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases.
Marion Thomas, M. Masson, S. Bitoun, S. Hamroun +6 more
2023Rheumatology7 citations
Semantic Scholar
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes
G. Lepri, P. Airó, O. Distler, K. Andréasson +30 more
2023Journal of Scleroderma and Related Disorders7 citations Open access
Semantic Scholar
Mouth opening in systemic sclerosis: A longitudinal analysis from the French national cohort study
B. Chaigne, Alexandre Bense, C. Agard, Y. Allanore +40 more
2023Journal of Internal Medicine6 citations
Semantic Scholar
POS1260 SYSTEMATIC LITERATURE REVIEW FOR THE 2023 UPDATE OF EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS
A. Lescoat, E. Bertoldo, J. Čolić, T. Santiago +5 more
2023Annals of the Rheumatic Diseases6 citations Open access
Semantic Scholar
Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practice.
J. Avouac, Rodolphe Cougnaud Murail, C. Goulvestre, S. Dumas +5 more
2022Seminars in Arthritis & Rheumatism6 citations Open access
Semantic Scholar
The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease
G. Boleto, J. Avouac, Y. Allanore
2022Therapeutic Advances in Musculoskeletal Disease6 citations Open access
Semantic Scholar
Comparison of subcutaneous and oral methotrexate initiation in rheumatoid arthritis in current practice.
P. Vidal-Montal, M. Thomas, A. Combier, A. Steelandt +6 more
2023Joint Bone Spine5 citations
Semantic Scholar
The Effect of Body Fat Distribution on Systemic Sclerosis
G. Villanueva-Martin, M. Acosta-Herrera, M. Kerick, E. López-Isac +14 more
2022Journal of Clinical Medicine5 citations Open access
Semantic Scholar
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis
D. Khanna, Frank Kramer, J. Höfler, M. Ghadessi +25 more
2024Rheumatology4 citations Open access
Semantic Scholar
Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study
M. Schmalzing, H. Kellner, Ayman Askari, Javier De Toro Santos +14 more
2023Advances in Therapy4 citations Open access
Semantic Scholar
OP0238 IMMUNOSUPPRESSION WITH TARGETED DMARDS REDUCES MORBIDITY AND MORTALITY IN PRE-CAPILLARY PULMONARY HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A EUSTAR ANALYSIS
C. Bruni, L. Tofani, H. Fretheim, Y. Weber +54 more
2023Annals of the Rheumatic Diseases4 citations Open access
Semantic Scholar
Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologists
María Paula Álvarez-Hernández, Y. Allanore, I. Andrade, M. H. Buch +8 more
2024Journal of Scleroderma and Related Disorders3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

O. Distler×21
Invite
O. Distler — researcher profile on SciRah
A. Hoffmann-Vold×20
Invite
A. Hoffmann-Vold — researcher profile on SciRah
M. Matucci-Cerinic×17
Invite
M. Matucci-Cerinic — researcher profile on SciRah
J. Avouac×14
Invite
J. Avouac — researcher profile on SciRah

×13

Invite

M. Kuwana — researcher profile on SciRah

Invite

C. Denton — researcher profile on SciRah

Invite

D. Khanna — researcher profile on SciRah

Invite

P. Airó — researcher profile on SciRah

Invite

V. Smith — researcher profile on SciRah

J. de Vries-Bouwstra×9

Invite

J. de Vries-Bouwstra — researcher profile on SciRah

F. del Galdo×9

Invite

F. del Galdo — researcher profile on SciRah

M. Truchetet×8

Invite

M. Truchetet — researcher profile on SciRah